Academic Journal
719TiP A phase I/Ib study of the Werner (WRN) helicase inhibitor HRO761 as single agent and in combination with irinotecan or tislelizumab in patients with microsatellite instability-high (MSIhi) or mismatch repair deficient (dMMR) advanced solid tumors
العنوان: | 719TiP A phase I/Ib study of the Werner (WRN) helicase inhibitor HRO761 as single agent and in combination with irinotecan or tislelizumab in patients with microsatellite instability-high (MSIhi) or mismatch repair deficient (dMMR) advanced solid tumors |
---|---|
المؤلفون: | Moschetta, M., Doi, T., Kuboki, Y., Sundar, R., Möbitz, H., Jaco, I., Cortes Cros, M., Ferretti, S., Jankovic, D., Thérier, M., Clementi, G., Li, Y., De Kanter, R., Quadt, C. |
المصدر: | Annals of Oncology ; volume 34, page S496 ; ISSN 0923-7534 |
بيانات النشر: | Elsevier BV |
سنة النشر: | 2023 |
المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1016/j.annonc.2023.09.1905 |
الاتاحة: | http://dx.doi.org/10.1016/j.annonc.2023.09.1905 https://api.elsevier.com/content/article/PII:S0923753423027424?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S0923753423027424?httpAccept=text/plain |
Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ |
رقم الانضمام: | edsbas.9570A8A |
قاعدة البيانات: | BASE |
DOI: | 10.1016/j.annonc.2023.09.1905 |
---|